Delivery Order SPE2DB22D2206-SPE2DB25FJF96
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,537.30 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) on October 23, 2025, with completion scheduled for October 24, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on April 23, 2025, valued at $7,818.08 for 100 tablets of CellCept 500 mg, with final delivery due by April 24, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) under a firm fixed-price contract valued at $17,337.23. This non-set-aside award was issued on December 11, 2025, with an ultimate completion date of December 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $1,268.65 firm fixed-price delivery order for 100 tablets of CellCept 500 mg by the Defense Logistics Agency on December 8, 2025, with an ultimate completion date of December 9, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (500-count units) valued at $14,887.62 under a firm fixed-price contract. The award, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery order executed without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its Corporate Office location,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,864.32, is a delivery order for the supply of 4,567,925,538 units of the medication CellCept 500 mg tablet. The contract is a firm fixed-price, non-set-aside award with a performance period extending through April 16, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on July 16, 2025, for CellCept 250 mg capsules (100-count units) with a ceiling value of $17,152.58. This firm fixed-price delivery order, which is due for completion by July 17, 2025, represents a non-set-aside competitive award under the broader pharmaceutical supply framework. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100 count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $27,735.62 and carries no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency Troop Support Medical awarded a $4,112.14 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 tablets of 500 mg Cellcept. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is August 3 to August 4, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the requested medication to support the Defense Logistics Agency's mission to...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $15,126.15 to supply 100 tablets of the pharmaceutical CELLCEPT 500 MG. Performance will take place in Conshohocken, Pennsylvania over one day from August 31st to September 1st, 2023. As a leading provider of pharmaceuticals and healthcare value-added services to the Department of Defense, Amerisourcebergen will fulfill this order from its Corporate Office Division to support the...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJF96Delivery Order
The Defense Logistics Agency awarded a $29,003.35 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of CellCept 500 mg tablets (500-count units). This is a firm fixed price, non-set-aside contract with a completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle valued through December 2026 that enables the company to furnish a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds a significant portfolio of federal medical procurement contracts, primarily with the Defense Logistics Agency and its Medical Supply Chain. The company's federal contracts demonstrate extensive capabilities in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare systems. As a prime contractor operating through open competition on non-set-aside contracts, AmerisourceBergen serves critical federal medical supply needs with firm fixed pricing arrangements ranging from modest to substantial order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.0k | 8/5/25 |